No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BOC240816C12500
- 1.50
- +0.80+114.29%
15min DelayClose Jul 23 15:52 ET
1.50High1.50Low
1.50Open0.70Pre Close1 Volume177 Open Interest12.50Strike Price150.00Turnover42.35%IV1.23%PremiumAug 16, 2024Expiry Date1.33Intrinsic Value100Multiplier23DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type0.8455Delta0.1584Gamma9.22Leverage Ratio-0.0089Theta0.0067Rho7.80Eff Leverage0.0084Vega
Intraday
- 5D
- Daily
News
Boston Omaha(BOC.US) 10% Shareholder Buys US$187.45K in Common Stock
Boston Omaha(BOC.US) Officer Buys US$20,041.14 in Common Stock
Boston Omaha(BOC.US) Director Buys US$420.98K in Common Stock
Boston Omaha Insider Bought Shares Worth $420,981, According to a Recent SEC Filing
President of Boston Omaha Picks Up 8.2% More Stock
Insider Buying: CEO Adam Peterson Acquires Shares of Boston Omaha Corp
Comments
Gainers:
• $Resolute Forest Products(RFP.US$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular(AMTI.US$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $Primoris Services(PRIM.US$ +2.1% (awarded a $170 mln project by Texas DOT)
• $Biogen(BIIB.US$ +2.1% (Bi...
• $Resolute Forest Products(RFP.US$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular(AMTI.US$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $Primoris Services(PRIM.US$ +2.1% (awarded a $170 mln project by Texas DOT)
• $Biogen(BIIB.US$ +2.1% (Bi...
14
3
Read more